RxDoctor Payments DataLook up a doctor →

Kendall Donaldson, MD

Ophthalmology · Miami, FLNPI 1013950237

Payments from drug & device makers

$351,475in general payments, 2019–2025

Across 496 payments — averaging $708.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Surgical Vision, Inc.$88K
  • AbbVie$49K
  • Alcon$43K
  • Novartis$21K
  • Bausch & Lomb Americas Inc.$16K
  • Dompe US, Inc.$14K
  • plus $120K from 30 others
$4,375in research payments, 2019–2025

Across 1 payment — averaging $4375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson Surgical Vision, Inc.113$88,420
AbbVie(2 entities)80$49,247
Alcon82$42,737
Novartis24$20,890
Bausch & Lomb Americas Inc.28$16,143
Dompe US, Inc.17$13,696
Alcon Research LLC10$13,113
Tarsus Pharmaceuticals, Inc.13$12,131
Omeros Corporation4$12,065
Glaukos Corporation15$11,145
Beaver-visitec International, Inc.5$9,705
Lumenis BE Inc3$8,821
Rayner Intraocular Lenses Limited3$8,760
Lensar, Inc.6$8,316
Carl Zeiss Meditec, Inc.7$7,367
Shire North American Group Inc6$4,236
Quidel Corporation9$2,903
Carl Zeiss Meditec Digital Innovations LLC1$2,792
Rxsight Inc12$2,631
Biotissue Holdings Inc.2$2,600
Eyevance Pharmaceuticals LLC7$2,387
Bausch & Lomb, A Division Of Bausch Health US, LLC5$2,355
Amgen2$2,063
Harrow Eye, LLC2$2,022
Sun Pharmaceutical Industries Inc.17$1,356
AstraZeneca1$1,300
Sight Sciences, Inc.2$763
Tearlab Corp1$500
Carl Zeiss Meditec USA, Inc.4$324
Johnson & Johnson Vision Care, Inc.2$263
Ocular Therapeutix, Inc.6$129
Ortho-clinical Diagnostics, Inc.1$123
Oyster Point Pharma, Inc.2$77
Mallinckrodt Enterprises LLC2$43
Kala Pharmaceuticals, Inc.1$38
Medline Industries LP1$16

How this compares

$351,475 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$290,662
Medicare patients
805
Services billed
2,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →